Search

everythinglearnresearchcommunity

for

Search:↓

Some skin medications can have harmful interactions with the COVID-19 drug nirmatrelvir-ritonavir, but not with molnupiravir.

Finasteride effectively treats male hair loss, increasing length and thickness.

Treating hair loss effectively may require a multi-sided approach, using different treatments together, and topical treatments could be more effective and safer than oral ones.

The conclusion is that endocrinology significantly impacts medicine with various common medications used for treatment.

Using hair loss drugs finasteride and dutasteride may cause sexual side effects.

Stopping sunscreen use on the forehead led to hair regrowth in a woman with frontal fibrosing alopecia.

A woman with severe angioedema improved significantly after treatment with rituximab.

Man experienced post-finasteride syndrome symptoms after using finasteride and dutasteride for hair loss.

Dutasteride may help stabilize Frontal Fibrosing Alopecia, but more research is needed.

5-alpha reductase inhibitors can cause sexual side effects like erectile dysfunction and reduced sexual desire, sometimes lasting after stopping the drug.

Dutasteride effectively treats enlarged prostate, reduces prostate cancer risk, and promotes hair regrowth with few side effects.

Finasteride and dutasteride effectively treat hair loss in men and women, but may cause side effects like low libido and depression.

Finasteride and low-dose dutasteride combo improves hair growth and reduces hair loss with no major side effects.

Special nanoparticles increased skin absorption of hair loss treatments with fewer side effects.

Finasteride and dutasteride increase sexual dysfunction risk by 1.57 times in male hair loss treatment.

Dutasteride-loaded nanoparticles coated with Lauric Acid-Chitosan show promise for treating hair loss due to their controlled release, low toxicity, and potential to stimulate hair growth.

The letter is skeptical about the effectiveness of anti-androgen therapy for COVID-19 and calls for strong evidence from clinical trials.

The document concludes that women should not use 5-alpha-reductase inhibitors due to the risk of birth defects and limited effectiveness.

Dutasteride, fesoterodine, and finasteride help older patients with urinary issues.

Most patients with frontal fibrosing alopecia are postmenopausal women, and treatments like finasteride and dutasteride can improve or stabilize the condition.

Testosterone's muscle-building effects do not require its conversion to DHT.

More men are getting benign prostatic hyperplasia, and there are many treatments, from medication to surgery, with new methods being developed.

High-dose dutasteride reduces PMDD symptoms by stabilizing neurosteroid levels.

Effective hair loss treatment in women requires correct diagnosis and can include medications like minoxidil, antiandrogens, and treatments for underlying conditions like PCOS.

5α-reductase inhibitors can cause sexual problems, higher risk of aggressive prostate cancer, and depression.

S5αR inhibitors might help treat schizophrenia and other mental disorders but need more research.

Finasteride and dutasteride effectively treat hair loss, but may cause side effects like sexual dysfunction and depression.

5α-reductase inhibitors increase the risk of sexual dysfunction, especially in men with enlarged prostate.

5α-reductase inhibitors and alpha-1 adrenergic antagonists together effectively treat benign prostatic hyperplasia, with long-term benefits.

Certain drugs that block specific enzymes can help treat prostate diseases.